View in EDS

Radionuclide-Aided Improvement of the Therapeutic Efficacy of Novel Antibody-Drug Conjugates against HER2-Expressing Cancers.

Saved in:
Bibliographic Details
Title: Radionuclide-Aided Improvement of the Therapeutic Efficacy of Novel Antibody-Drug Conjugates against HER2-Expressing Cancers.
Authors: Kang CS; Division of Applied RI, Korea Institute of Radiological and Medical Sciences, Seoul 01812, Republic of Korea.; Radiological and Medico-Oncological Sciences, University of Science and Technology, Daejeon 34113, Republic of Korea., Kim DH; Division of Applied RI, Korea Institute of Radiological and Medical Sciences, Seoul 01812, Republic of Korea.; Department of Life Sciences, College of Life Sciences and Biotechnology, Korea University, Seoul 02841, Republic of Korea., Lim H; Division of Applied RI, Korea Institute of Radiological and Medical Sciences, Seoul 01812, Republic of Korea.; Radiological and Medico-Oncological Sciences, University of Science and Technology, Daejeon 34113, Republic of Korea., Kim S; Division of Applied RI, Korea Institute of Radiological and Medical Sciences, Seoul 01812, Republic of Korea.; Radiological and Medico-Oncological Sciences, University of Science and Technology, Daejeon 34113, Republic of Korea., Almaslamani M; Division of Applied RI, Korea Institute of Radiological and Medical Sciences, Seoul 01812, Republic of Korea.; Radiological and Medico-Oncological Sciences, University of Science and Technology, Daejeon 34113, Republic of Korea., Kang CM; Division of Applied RI, Korea Institute of Radiological and Medical Sciences, Seoul 01812, Republic of Korea.; Radiological and Medico-Oncological Sciences, University of Science and Technology, Daejeon 34113, Republic of Korea., Woo SK; Division of Applied RI, Korea Institute of Radiological and Medical Sciences, Seoul 01812, Republic of Korea.; Radiological and Medico-Oncological Sciences, University of Science and Technology, Daejeon 34113, Republic of Korea.
Source: Molecular pharmaceutics [Mol Pharm] 2025 Jul 07; Vol. 22 (7), pp. 3793-3802. Date of Electronic Publication: 2025 May 31.
Publication Type: Journal Article; Research Support, Non-U.S. Gov't
Journal Info: Publisher: American Chemical Society Country of Publication: United States NLM ID: 101197791 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1543-8392 (Electronic) Linking ISSN: 15438384 NLM ISO Abbreviation: Mol Pharm Subsets: MEDLINE
Database: MEDLINE Ultimate
FullText Text:
  Availability: 0
Header DbId: mdl
DbLabel: MEDLINE Ultimate
An: 40448644
AccessLevel: 2
PubType: Academic Journal
PubTypeId: academicJournal
PreciseRelevancyScore: 0
IllustrationInfo
Items – Name: Title
  Label: Title
  Group: Ti
  Data: Radionuclide-Aided Improvement of the Therapeutic Efficacy of Novel Antibody-Drug Conjugates against HER2-Expressing Cancers.
– Name: Author
  Label: Authors
  Group: Au
  Data: <searchLink fieldCode="AU" term="%22Kang+CS%22">Kang CS</searchLink>; Division of Applied RI, Korea Institute of Radiological and Medical Sciences, Seoul 01812, Republic of Korea.; Radiological and Medico-Oncological Sciences, University of Science and Technology, Daejeon 34113, Republic of Korea.<br /><searchLink fieldCode="AU" term="%22Kim+DH%22">Kim DH</searchLink>; Division of Applied RI, Korea Institute of Radiological and Medical Sciences, Seoul 01812, Republic of Korea.; Department of Life Sciences, College of Life Sciences and Biotechnology, Korea University, Seoul 02841, Republic of Korea.<br /><searchLink fieldCode="AU" term="%22Lim+H%22">Lim H</searchLink>; Division of Applied RI, Korea Institute of Radiological and Medical Sciences, Seoul 01812, Republic of Korea.; Radiological and Medico-Oncological Sciences, University of Science and Technology, Daejeon 34113, Republic of Korea.<br /><searchLink fieldCode="AU" term="%22Kim+S%22">Kim S</searchLink>; Division of Applied RI, Korea Institute of Radiological and Medical Sciences, Seoul 01812, Republic of Korea.; Radiological and Medico-Oncological Sciences, University of Science and Technology, Daejeon 34113, Republic of Korea.<br /><searchLink fieldCode="AU" term="%22Almaslamani+M%22">Almaslamani M</searchLink>; Division of Applied RI, Korea Institute of Radiological and Medical Sciences, Seoul 01812, Republic of Korea.; Radiological and Medico-Oncological Sciences, University of Science and Technology, Daejeon 34113, Republic of Korea.<br /><searchLink fieldCode="AU" term="%22Kang+CM%22">Kang CM</searchLink>; Division of Applied RI, Korea Institute of Radiological and Medical Sciences, Seoul 01812, Republic of Korea.; Radiological and Medico-Oncological Sciences, University of Science and Technology, Daejeon 34113, Republic of Korea.<br /><searchLink fieldCode="AU" term="%22Woo+SK%22">Woo SK</searchLink>; Division of Applied RI, Korea Institute of Radiological and Medical Sciences, Seoul 01812, Republic of Korea.; Radiological and Medico-Oncological Sciences, University of Science and Technology, Daejeon 34113, Republic of Korea.
– Name: TitleSource
  Label: Source
  Group: Src
  Data: <searchLink fieldCode="JN" term="%22101197791%22">Molecular pharmaceutics</searchLink> [Mol Pharm] 2025 Jul 07; Vol. 22 (7), pp. 3793-3802. <i>Date of Electronic Publication: </i>2025 May 31.
– Name: TypePub
  Label: Publication Type
  Group: TypPub
  Data: Journal Article; Research Support, Non-U.S. Gov't
– Name: TitleSource
  Label: Journal Info
  Group: Src
  Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22American+Chemical+Society%22">American Chemical Society </searchLink><i>Country of Publication: </i>United States <i>NLM ID: </i>101197791 <i>Publication Model: </i>Print-Electronic <i>Cited Medium: </i>Internet <i>ISSN: </i>1543-8392 (Electronic) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%2215438384%22">15438384 </searchLink><i>NLM ISO Abbreviation: </i>Mol Pharm <i>Subsets: </i>MEDLINE
PLink https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=40448644
RecordInfo BibRecord:
  BibEntity:
    Identifiers:
      – Type: doi
        Value: 10.1021/acs.molpharmaceut.5c00043
    Languages:
      – Code: eng
        Text: English
    PhysicalDescription:
      Pagination:
        StartPage: 3793
    Titles:
      – TitleFull: Radionuclide-Aided Improvement of the Therapeutic Efficacy of Novel Antibody-Drug Conjugates against HER2-Expressing Cancers.
        Type: main
  BibRelationships:
    HasContributorRelationships:
      – PersonEntity:
          Name:
            NameFull: Kang CS
      – PersonEntity:
          Name:
            NameFull: Kim DH
      – PersonEntity:
          Name:
            NameFull: Lim H
      – PersonEntity:
          Name:
            NameFull: Kim S
      – PersonEntity:
          Name:
            NameFull: Almaslamani M
      – PersonEntity:
          Name:
            NameFull: Kang CM
      – PersonEntity:
          Name:
            NameFull: Woo SK
    IsPartOfRelationships:
      – BibEntity:
          Dates:
            – D: 07
              M: 07
              Text: 2025 Jul 07
              Type: published
              Y: 2025
          Identifiers:
            – Type: issn-electronic
              Value: 1543-8392
          Numbering:
            – Type: volume
              Value: 22
            – Type: issue
              Value: 7
          Titles:
            – TitleFull: Molecular pharmaceutics
              Type: main
ResultId 1